BACKGROUND: Amplicon deep sequencing permits sensitive detection of minority clones and improves discriminatory power for genotyping multi-clone Plasmodium falciparum infections. New amplicon sequencing and data analysis protocols are needed for genotyping in epidemiological studies and drug efficacy trials of P. falciparum. METHODS: Targeted sequencing of molecular marker csp and novel marker cpmp was conducted in duplicate on mixtures of parasite culture strains and 37 field samples. A protocol allowing to multiplex up to 384 samples in a single sequencing run was applied. Software "HaplotypR" was developed for data analysis. RESULTS: Cpmp was highly diverse (He = 0.96) in contrast to csp (He = 0.57). Minority clones were robustly detecte...
Malaria elimination strategies require surveillance of the parasite population for genetic changes t...
Abstract Background Multiplicity of infection (MOI) is an important measure of Plasmodium falciparum...
BACKGROUND:Parasite genetic diversity and multiplicity of infection (MOI) affect clinical outcomes, ...
Abstract Background Amplicon deep sequencing permits sensitive detection of minority clones and impr...
Clinical trials monitoring malaria drug resistance require genotyping of recurrent Plasmodium falcip...
Longitudinal tracking of individual Plasmodium falciparum strains in multi-clonal infections is esse...
BACKGROUND: Humans living in regions with high falciparum malaria transmission intensity harbour mul...
BACKGROUND: Targeted next-generation sequencing offers the potential for consistent, deep coverage o...
The diversity in the Plasmodium falciparum genome can be used to explore parasite population dynamic...
The diversity in the Plasmodium falciparum genome can be used to explore parasite population dynamic...
Naturally acquired blood-stage infections of the malaria parasite Plasmodium falciparum typically ha...
Estimation of drug efficacy in antimalarial drug trials requires parasite genotyping to distinguish ...
Abstract Genetic diversity of malaria parasites represents a major issue in understanding several as...
These extended data accompany the manuscript: Targeted Amplicon deep sequencing of ama1 and mdr1 to ...
Molecular surveillance for drug-resistant malaria parasites requires reliable, timely, and scalable ...
Malaria elimination strategies require surveillance of the parasite population for genetic changes t...
Abstract Background Multiplicity of infection (MOI) is an important measure of Plasmodium falciparum...
BACKGROUND:Parasite genetic diversity and multiplicity of infection (MOI) affect clinical outcomes, ...
Abstract Background Amplicon deep sequencing permits sensitive detection of minority clones and impr...
Clinical trials monitoring malaria drug resistance require genotyping of recurrent Plasmodium falcip...
Longitudinal tracking of individual Plasmodium falciparum strains in multi-clonal infections is esse...
BACKGROUND: Humans living in regions with high falciparum malaria transmission intensity harbour mul...
BACKGROUND: Targeted next-generation sequencing offers the potential for consistent, deep coverage o...
The diversity in the Plasmodium falciparum genome can be used to explore parasite population dynamic...
The diversity in the Plasmodium falciparum genome can be used to explore parasite population dynamic...
Naturally acquired blood-stage infections of the malaria parasite Plasmodium falciparum typically ha...
Estimation of drug efficacy in antimalarial drug trials requires parasite genotyping to distinguish ...
Abstract Genetic diversity of malaria parasites represents a major issue in understanding several as...
These extended data accompany the manuscript: Targeted Amplicon deep sequencing of ama1 and mdr1 to ...
Molecular surveillance for drug-resistant malaria parasites requires reliable, timely, and scalable ...
Malaria elimination strategies require surveillance of the parasite population for genetic changes t...
Abstract Background Multiplicity of infection (MOI) is an important measure of Plasmodium falciparum...
BACKGROUND:Parasite genetic diversity and multiplicity of infection (MOI) affect clinical outcomes, ...